When designing a product, a manufacturer has a duty to exercise care in selecting from among alternative product designs to reduce the foreseeable risks of harm presented in the use of the product.

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...

Background: Apixaban (2.5 mg) taken twice daily has been shown to substantially reduce the risk of venous thromboembolism (VTE) compared with placebo for the primary thromboprophylaxis of ambulatory ...

Is it cost-effective? This question is increasingly asked about health interventions as we attempt to achieve the maximum benefit from limited health care resources. As a result, cost–effectiveness ...

Families are projected to pay nearly $1,000 on average for their utility bills during the winter months, according to analysis from the Century Foundation. Over the past three years, utility bill ...